ARLINGTON, Va., Nov. 18, 2013 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on the passage of national pharmaceutical traceability legislation (Drug Quality and Security Act/H.R. 3204) by the U.S. Senate.
"Today the Senate voted to establish a national traceability framework for prescription medicines. The federal preemption of state laws to further strengthen the U.S. pharmaceutical supply chain represents one of the most significant legislative accomplishments for our industry and, is especially important for the healthcare providers and pharmacies — and their patients — who count on the safe and efficient distribution of prescription medicines. Thanks to the commitment and hard work of the U.S. Congress, the 50-state patchwork of regulations will be replaced with one federal solution, ensuring the seamless movement and traceability of pharmaceuticals throughout the supply chain. This victory is the culmination of nearly a decade's worth of work by HDMA and all those who championed this issue. We applaud Congress for passing legislation to establish one national solution for a safer, more secure pharmaceutical supply chain, and urge President Obama to swiftly sign the bill into law."
Continue the conversation about federal pharmaceutical traceability on Twitter through the hashtag #1RxSolution.
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system. For more information, visit www.HealthcareDistribution.org.
|SOURCE Healthcare Distribution Management Association|
Copyright©2012 PR Newswire.
All rights reserved